Type-III interferon stimulated gene TRIM31 mutation in an HBV patient blocks its ability in promoting HBx degradation

Virus Res. 2022 Jan 15:308:198650. doi: 10.1016/j.virusres.2021.198650. Epub 2021 Dec 1.

Abstract

TRIM5γ, together with TRIM31, has been shown to promote HBx ubiquitination and degradation. This study aimed to explore whether a patient with HCC (hepatic cell carcinoma) having a small nucleotide inserted into the TRIM31 gene, which made a shorter transcript stop at 768 bp, would result in blocking the activity of TRIM31 in promoting HBx degradation. Besides, this study aimed to determine the binding region of the TRIM31-TRIM5γ-HBx complex. HBV (Hepatitis B virus) infection was reported to induce type-III IFN but not type-I or type-II IFNs, here TRIM31 was found to be a type III rather than a type I stimulated gene, which was indispensable in inhibiting the hepatitis B virus replication by the interferon families. Thus, this study further identified the critical role of TRIM31 in the host-hepatitis B virus interaction.

Keywords: HBx; Hepatitis B virus (HBV); Interferon; TRIM31.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Hepatocellular* / genetics
  • Hep G2 Cells
  • Hepatitis B virus / genetics
  • Hepatitis B virus / metabolism
  • Hepatitis B*
  • Humans
  • Interferons / genetics
  • Liver Neoplasms*
  • Mutation
  • Trans-Activators / genetics
  • Trans-Activators / metabolism*
  • Tripartite Motif Proteins / genetics
  • Ubiquitin-Protein Ligases / genetics
  • Ubiquitin-Protein Ligases / metabolism
  • Viral Regulatory and Accessory Proteins / genetics
  • Viral Regulatory and Accessory Proteins / metabolism*
  • Virus Replication / genetics

Substances

  • Trans-Activators
  • Tripartite Motif Proteins
  • Viral Regulatory and Accessory Proteins
  • hepatitis B virus X protein
  • Interferons
  • TRIM31 protein, human
  • Ubiquitin-Protein Ligases